4746
vs
T
Taiwan Weighted Index
4746
Over the past 12 months, Formosa Laboratories Inc has underperformed Taiwan Weighted Index, delivering a return of -24% compared to the Taiwan Weighted Index's +56% growth.
Stocks Performance
4746 vs Taiwan Weighted Index
Performance Gap
4746 vs Taiwan Weighted Index
Performance By Year
4746 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
